Different Heterocycles Functionalized<i>s</i>-Triazine Analogues: Design, Synthesis and<i>In Vitro</i>Antimicrobial, Antituberculosis, and Anti-HIV Assessment
作者:Paresh K. Patel、Rahul V. Patel、Dharmesh H. Mahajan、Parimal A. Parikh、Girish N. Mehta、Christophe Pannecouque、Erik De Clercq、Kishor H. Chikhalia
DOI:10.1002/jhet.1769
日期:2014.11
spectrum antimicrobial (MICs: 6.25–25 µg/mL) and antitubercular (MIC: 12.5 µg/mL) potential. Hence, anti‐HIV activity against two types of HIV viral strains [HIV‐1 (IIIB) and HIV‐2 (ROD)] has been carried out using the MTT assay. From this bioassay, we have identified some potent inhibitors acting as anti‐HIV‐1 agents (IC50: 4.45 µg/mL) with promising therapeutic index of 16 for analogue 7 h. The structural
冷凝一些新喹诺酮小号赋予了不同的杂环和4-氨基苄腈部分嗪衍生物已被合成,并检测其对8种细菌的生物活性(金黄色葡萄球菌,蜡样芽胞杆菌,大肠杆菌,铜绿假单胞菌,肺炎克雷伯菌,伤寒沙门菌,普通变形杆菌,和弗氏志贺菌),两种真菌(黑曲霉,白色念珠菌),通过使用琼脂稀释条纹方法,和结核分枝杆菌通过使用Lowenstein和Jensen MIC方法获得H37Rv。经过初步的生物学筛选,发现大多数化合物具有显着的广谱抗菌作用(MIC:6.25–25 µg / mL)和抗结核药(MIC:12.5 µg / mL)。因此,已经使用MTT测定法针对两种类型的HIV病毒株[HIV-1(III B)和HIV-2(ROD)]进行了抗HIV活性研究。通过该生物测定法,我们已经鉴定出一些有效的抑制剂可作为抗HIV-1药物(IC 50:4.45 µg / mL),对类似物7 h的治疗指数有望达到16。在IR,1 H NMR,13